Trials / Completed
CompletedNCT03124927
Accuracy of Methemoglobin Measurement for Rainbow DCI Sensors
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 25 (actual)
- Sponsor
- Masimo Corporation · Industry
- Sex
- All
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
In this study, the level of methemoglobin (HbMet) will be increased in a controlled manner by administering sodium nitrite intravenously in healthy volunteers. The accuracy of a noninvasive HbMet measurement by a DCI pulse oximeter sensor will be assessed by comparison to blood measurements from a laboratory analyzer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | DCI pulse oximeter sensor |
Timeline
- Start date
- 2008-04-23
- Primary completion
- 2008-08-08
- Completion
- 2008-08-08
- First posted
- 2017-04-24
- Last updated
- 2017-06-12
- Results posted
- 2017-06-12
Locations
2 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03124927. Inclusion in this directory is not an endorsement.